CoreWeave (CRWV) Chief Development Officer reports 10b5-1 stock sales

Rhea-AI Filing Summary

CoreWeave, Inc. reported that its Chief Development Officer, a company officer, indirectly sold shares of Class A common stock on 12/15/2025. The transactions were executed through several related entities, including Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC, and the Canis Major and Canis Minor 2025 GRATs, where the officer or the officer’s spouse serves as manager, trustee, or beneficiary.

The filing states that these sales were made under a Rule 10b5-1 trading plan adopted on September 2, 2025, and were reported as open-market sales at various weighted average prices in the $70s per share. After the trades, the reported indirect holdings in several of these trusts and GRATs were reduced, with some entities showing zero remaining shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McBee Brannin

(Last) (First) (Middle)

C/O COREWEAVE, INC.

290 WEST MT. PLEASANT AVENUE, SUITE 4100

(Street)

LIVINGSTON NJ 07039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/15/2025		S(1)		403	D	$72.5224(2)	597	I	Canis Major 2025 Family Trust LLC(3)
Class A Common Stock	12/15/2025		S(1)		445	D	$73.7287(4)	152	I	Canis Major 2025 Family Trust LLC(3)
Class A Common Stock	12/15/2025		S(1)		61	D	$74.5231(5)	91	I	Canis Major 2025 Family Trust LLC(3)
Class A Common Stock	12/15/2025		S(1)		37	D	$76.3654(6)	54	I	Canis Major 2025 Family Trust LLC(3)
Class A Common Stock	12/15/2025		S(1)		36	D	$78.855(7)	18	I	Canis Major 2025 Family Trust LLC(3)
Class A Common Stock	12/15/2025		S(1)		18	D	$79.69	0	I	Canis Major 2025 Family Trust LLC(3)
Class A Common Stock	12/15/2025		S(1)		403	D	$72.5228(2)	597	I	Canis Minor 2025 Family Trust LLC(8)
Class A Common Stock	12/15/2025		S(1)		445	D	$73.7293(4)	152	I	Canis Minor 2025 Family Trust LLC(8)
Class A Common Stock	12/15/2025		S(1)		61	D	$74.5231(5)	91	I	Canis Minor 2025 Family Trust LLC(8)
Class A Common Stock	12/15/2025		S(1)		36	D	$76.355(6)	55	I	Canis Minor 2025 Family Trust LLC(8)
Class A Common Stock	12/15/2025		S(1)		37	D	$78.8495(7)	18	I	Canis Minor 2025 Family Trust LLC(8)
Class A Common Stock	12/15/2025		S(1)		18	D	$79.69	0	I	Canis Minor 2025 Family Trust LLC(8)
Class A Common Stock	12/15/2025		S(1)		10,140	D	$72.4923(9)	14,860	I	Canis Major 2025 GRAT(10)
Class A Common Stock	12/15/2025		S(1)		10,077	D	$73.6677(11)	4,783	I	Canis Major 2025 GRAT(10)
Class A Common Stock	12/15/2025		S(1)		2,852	D	$74.3739(12)	1,931	I	Canis Major 2025 GRAT(10)
Class A Common Stock	12/15/2025		S(1)		501	D	$75.5933(13)	1,430	I	Canis Major 2025 GRAT(10)
Class A Common Stock	12/15/2025		S(1)		376	D	$76.573(14)	1,054	I	Canis Major 2025 GRAT(10)
Class A Common Stock	12/15/2025		S(1)		496	D	$78.2976(15)	558	I	Canis Major 2025 GRAT(10)
Class A Common Stock	12/15/2025		S(1)		558	D	$79.382(16)	0	I	Canis Major 2025 GRAT(10)
Class A Common Stock	12/15/2025		S(1)		3,381	D	$72.4923(9)	4,954	I	Canis Minor 2025 GRAT(17)
Class A Common Stock	12/15/2025		S(1)		3,360	D	$73.6678(11)	1,594	I	Canis Minor 2025 GRAT(17)
Class A Common Stock	12/15/2025		S(1)		950	D	$74.3737(12)	644	I	Canis Minor 2025 GRAT(17)
Class A Common Stock	12/15/2025		S(1)		168	D	$75.5939(13)	476	I	Canis Minor 2025 GRAT(17)
Class A Common Stock	12/15/2025		S(1)		125	D	$76.5765(14)	351	I	Canis Minor 2025 GRAT(17)
Class A Common Stock	12/15/2025		S(1)		165	D	$78.2982(15)	186	I	Canis Minor 2025 GRAT(17)
Class A Common Stock	12/15/2025		S(1)		186	D	$79.3809(16)	0	I	Canis Minor 2025 GRAT(17)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.19 to $73.01, inclusive.

3. The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.20 to $74.16, inclusive.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.30 to $74.94, inclusive.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.97 to $76.74, inclusive.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.06, inclusive.

8. The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $73.07, inclusive.

10. The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.

11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.08 to $74.07, inclusive.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.08 to $75.03, inclusive.

13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.08 to $76.06, inclusive.

14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.10 to $77.07, inclusive.

15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $78.80, inclusive.

16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.11 to $79.69, inclusive.

17. The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.

Remarks:

This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person reported on Table I are continued on Part 3.

	/s/ Nisha Antony, as Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did CoreWeave (CRWV) report in this Form 4?

The report shows that CoreWeave’s Chief Development Officer indirectly sold shares of Class A common stock on 12/15/2025 through multiple family trusts and GRATs.

Were the CoreWeave (CRWV) stock sales made under a Rule 10b5-1 plan?

Yes. The filing notes that the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

Which entities sold CoreWeave (CRWV) shares in this insider transaction?

The reported sales were made indirectly through Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC, Canis Major 2025 GRAT, and Canis Minor 2025 GRAT.

What prices were received for the CoreWeave (CRWV) shares sold?

The filing reports weighted average prices for each line item, with explanatory notes stating that the shares were sold in multiple transactions at prices within specified ranges, generally in the $70s per share.

How are the family trusts and GRATs related to the CoreWeave (CRWV) officer?

The filing states that the officer serves as manager of the Canis Major and Canis Minor 2025 Family Trust LLCs, is the sole trustee and beneficiary of the Canis Major 2025 GRAT, and that the officer’s spouse is the sole beneficiary and trustee of the Canis Minor 2025 GRAT.

Did the reported CoreWeave (CRWV) trusts retain any shares after the sales?

The table shows that the amount of securities beneficially owned by each trust and GRAT changed after the transactions, with several entities reporting zero remaining shares following the sales.